AI Article Synopsis

  • Scientists created a new tool called IL-VIS that helps track and show changes in experiments over time, instead of just showing one moment.
  • IL-VIS learns from the data as new information comes in and gives a clear picture of how things are changing, which is better than older methods.
  • The researchers tested IL-VIS with both fake and real data from brain organoids to see how they reacted to a substance related to diseases like Alzheimer's, finding important information about their development and reactions.

Article Abstract

Longitudinal studies that continuously generate data enable the capture of temporal variations in experimentally observed parameters, facilitating the interpretation of results in a time-aware manner. We propose IL-VIS (incrementally learned visualizer), a new machine learning pipeline that incrementally learns and visualizes a progression trajectory representing the longitudinal changes in longitudinal studies. At each sampling time point in an experiment, IL-VIS generates a snapshot of the longitudinal process on the data observed thus far, a new feature that is beyond the reach of classical static models. We first verify the utility and correctness of IL-VIS using simulated data, for which the true progression trajectories are known. We find that it accurately captures and visualizes the trends and (dis)similarities between high-dimensional progression trajectories. We then apply IL-VIS to longitudinal multi-electrode array data from brain cortical organoids when exposed to different levels of quinolinic acid, a metabolite contributing to many neuroinflammatory diseases including Alzheimer's disease, and its blocking antibody. We uncover valuable insights into the organoids' electrophysiological maturation and response patterns over time under these conditions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11169470PMC
http://dx.doi.org/10.1038/s41598-024-63511-zDOI Listing

Publication Analysis

Top Keywords

incrementally learned
8
longitudinal studies
8
progression trajectories
8
longitudinal
6
data
5
visualization incrementally
4
learned projection
4
projection trajectories
4
trajectories longitudinal
4
longitudinal data
4

Similar Publications

The Internet of Things (IoT) and Industrial Internet of Things (IIoT) have drastically transformed industries by enhancing efficiency and flexibility but have also introduced substantial cybersecurity risks. The rise of zero-day attacks, which exploit unknown vulnerabilities, poses significant threats to these interconnected systems. Traditional signature-based intrusion detection systems (IDSs) are insufficient for detecting such attacks due to their reliance on pre-defined attack signatures.

View Article and Find Full Text PDF

Accurate depth estimation is crucial for many fields, including robotics, navigation, and medical imaging. However, conventional depth sensors often produce low-resolution (LR) depth maps, making detailed scene perception challenging. To address this, enhancing LR depth maps to high-resolution (HR) ones has become essential, guided by HR-structured inputs like RGB or grayscale images.

View Article and Find Full Text PDF

Background: Data on the predictive value of coronary computed tomography angiography-derived fractional flow reserve (CT-FFR) for long-term outcomes are limited.

Methods And Results: A retrospective pooled analysis of individual patient data was performed. Deep-learning-based CT-FFR was calculated.

View Article and Find Full Text PDF

Developing accurate and equitable screening protocols can lead to more targeted, efficient, and effective, teen dating violence (TDV) prevention programming. Current TDV screening protocols perform poorly and are rarely implemented, but recent research and policy emphasizes the importance of leveraging more trauma-focused screening measures for improved prevention outcomes. In response, the present study examined which adversities (i.

View Article and Find Full Text PDF

Neoadjuvant immunotherapies have shown antitumor activity in melanoma. Substudy 02C of the global, rolling-arm, phase 1/2, adaptive-design KEYMAKER-U02 trial is evaluating neoadjuvant pembrolizumab (anti-PD-1) alone or in combination, followed by adjuvant pembrolizumab, for stage IIIB-D melanoma. Here we report results from the first three arms: pembrolizumab plus vibostolimab (anti-TIGIT), pembrolizumab plus gebasaxturev (coxsackievirus A21) and pembrolizumab monotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!